Xu LP - Search Results

1

A prognostic model (BATAP) with external validation for patients with transplant-associated thrombotic microangiopathy.

Zhao P, Wu YJ, He Y, Chong S, Qu QY, Deng RX, Sun XW, Huang QS, Liu X, Zhu XL, Wang FR, Zhang YY, Mo XD, Han W, Wang JZ, Wang Y, Chen H, Chen YH, Zhao XY, Chang YJ, Xu LP, Liu KY, Huang XJ, Zhang XH. Zhao P, et al. Among authors: xu lp. Blood Adv. 2021 Dec 28;5(24):5479-5489. doi: 10.1182/bloodadvances.2021004530. Blood Adv. 2021. PMID: 34507352 Free PMC article.

2

[A clinical study of 19 cases of unrelated heterogenic bone marrow transplantation].

Xu L, Huang X, Ren H, Zhang Y, Guo N, Lu D. Xu L, et al. Zhonghua Nei Ke Za Zhi. 2002 Apr;41(4):256-8. Zhonghua Nei Ke Za Zhi. 2002. PMID: 12133439 Clinical Trial. Chinese.

3

[Hyperacute graft versus host disease after allo-stem cell transplantation, analysis of 118 cases].

Huang X, Chen Y, Guo N, Ren H, Zhang Y, Xu L, Gao Z, Lu D. Huang X, et al. Zhonghua Yi Xue Za Zhi. 2002 Apr 25;82(8):511-4. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12133493 Chinese.

4

[Allogeneic peripheral blood stem cell transplantation in the treatment of hematologic malignancies].

Wang F, Huang X, Ren H, Zhang Y, Xu L, Chen Y, Liu K, Guo N, Lu D. Wang F, et al. Zhonghua Xue Ye Xue Za Zhi. 2002 Aug;23(8):403-6. Zhonghua Xue Ye Xue Za Zhi. 2002. PMID: 12411042 Chinese.

5

[A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].

Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D. Chen Y, et al. Zhonghua Yi Xue Za Zhi. 2002 Oct 10;82(19):1306-9. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12509932 Chinese.

6

[Exploration of acute graft versus host disease and its risk factors after allo-hematopoietic stem cell transplantation].

Chen YH, Huang XJ, Guo NL, Ren HY, Zhang YC, Xu LP, Gao ZY, Lu DP. Chen YH, et al. Among authors: xu lp. Zhonghua Xue Ye Xue Za Zhi. 2003 Feb;24(2):61-3. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12697096 Chinese.

7

[Unrelated cord blood transplantation for the treatment of hematological malignancies].

Ren HY, Zhang YC, Huang XJ, Xu LP, Liu KY, Li D, Guo NL, Lu DP. Ren HY, et al. Among authors: xu lp. Zhonghua Xue Ye Xue Za Zhi. 2003 Feb;24(2):82-5. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12697102 Chinese.

8

[Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibody].

Lu J, Xu LP, Huang XJ, Chen H, Zhang YC, Ren HY, Guo NL, Lu DP. Lu J, et al. Among authors: xu lp. Zhonghua Yi Xue Za Zhi. 2003 Feb 10;83(3):216-9. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12812665 Chinese.

9

[Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].

Huang XJ, Xu LP, Ren HY, Zhang YC, Guo NL, Lu DP. Huang XJ, et al. Among authors: xu lp. Zhonghua Yi Xue Za Zhi. 2003 May 10;83(9):766-9. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12899755 Chinese.

10

[Pre-emptive antiviral therapy guided by extended routine plasma polymerase chain reaction surveillance].

Xu L, Huang X, Guo N, Ren H, Zhang Y, Lu D. Xu L, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2003 Apr 18;35(2):132-5. Beijing Da Xue Xue Bao Yi Xue Ban. 2003. PMID: 12920826 Free article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

829 results

Search Page

Filters